6:32 PM
 | 
Dec 29, 2014
 |  BC Extra  |  Top Story

Biotech stocks recovering from Bloody Tuesday

The BioCentury 100 and the NYSE Arca Biotechnology (BTK) indexes both edged up for a third day on Monday after dropping last week in the fallout from news that Express Scripts Holding Co. (NASDAQ:ESRX) had fired the first shot in the payer war on HCV drug prices.

The BioCentury 100 has regained 3% since tumbling 5% last Tuesday and the BTK has bounced back 4%, matching last week's selloff.

Gilead Sciences Inc. (NASDAQ:GILD) has regained $17.1...

Read the full 379 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >